Content Stream
Cured
Study Shows Mepolizumab to Be a Safe and Effective Long-Term Treatment Option for Severe Asthma
The Asthma and Allergy Foundation of America is sharing this press release from GlaxoSmithKline to bring you the latest research news quickly. [PRESS RELEASE] Nucala (mepolizumab) study reports long-term safety data, consistent exacerbation reduction and improved asthma control New study showed one third of patients had no exacerbations on long-term treatment with Nucala GlaxoSmithKline plc (GSK) today presented new data from the longest study of an anti-IL5 biologic treatment in severe...
AAFA Blog Named One of Best Asthma Blogs of 2018
We are proud to announce that the Asthma and Allergy Foundation of America’s blog has again been named one of the best asthma blogs by Healthline in 2018! Healthline is a health site with information on many health topics.
Creating an Asthma Management Plan in Philadelphia, Pennsylvania, the #4 Asthma Capital
When Joey was 4 years old, his parents took him to see an allergist. He was having trouble breathing and having challenges with his digestive system. They learned that Joey has asthma triggered by environmental and food allergies.